| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abstract
|
|
|
|
|
S1 |
p.
|
artikel
|
| 2 |
Abstract
|
|
|
|
|
S1 |
p. 1-368
|
artikel
|
| 3 |
Abstracts
|
|
|
|
|
S1 |
p. 1-1451
|
artikel
|
| 4 |
Aims and Scope
|
|
|
|
|
S1 |
p.
|
artikel
|
| 5 |
Author Index
|
|
|
|
|
S1 |
p. 1-21
|
artikel
|
| 6 |
Author Index
|
|
|
|
|
S1 |
p. 1-70
|
artikel
|
| 7 |
Author Index
|
|
|
|
|
S1 |
p.
|
artikel
|
| 8 |
Author Index
|
|
|
|
|
S1 |
p. 1-57
|
artikel
|
| 9 |
Author Index
|
|
|
|
|
S1 |
p. 1-15
|
artikel
|
| 10 |
Author Index
|
|
|
|
|
S1 |
p.
|
artikel
|
| 11 |
Editorial Board
|
|
|
|
|
S1 |
p.
|
artikel
|
| 12 |
HTRS2023.O8A.3 Bringing PERT to pediatrics: implementing and examining outcomes of the first pediatric Pulmonary Embolism Response Team (PERT)
|
Dang, Mary
|
|
|
|
S1 |
p.
|
artikel
|
| 13 |
HTRS2023.O8A.2 Exercise capacity is reduced in children and adolescents following pulmonary embolism
|
Parker, Mackenzie
|
|
|
|
S1 |
p.
|
artikel
|
| 14 |
HTRS2023.O6A.3 Identification of major bleeding depends on the definition: an analysis of the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database
|
Junior, Alexandre Soares Ferreira
|
|
|
|
S1 |
p.
|
artikel
|
| 15 |
HTRS2023.O6A.1 Leveraging quantitative platelet adhesion and platelet geometry-sensing assays to evaluate platelet function in type 1 von Willebrand disease
|
Azer, Sally
|
|
|
|
S1 |
p.
|
artikel
|
| 16 |
HTRS2023.O6A.2 Mobile application measurement of menstrual cycle characteristics and its association with dysmenorrhea and activity limitation in early adolescents
|
Bala, Natasha S.
|
|
|
|
S1 |
p.
|
artikel
|
| 17 |
HTRS2023.O8A.1 Plasmic (PLASMICkid) score for pediatric thrombotic thrombocytopenic purpura
|
Rairikar, Mugdha
|
|
|
|
S1 |
p.
|
artikel
|
| 18 |
HTRS2023.O6A.4 Proteomic analysis reveals proteins that are differently expressed in factor XI-deficient non-bleeders and bleeders
|
Reitsma, Stéphanie E.
|
|
|
|
S1 |
p.
|
artikel
|
| 19 |
HTRS2023.O8A.4 Proton pump inhibitors are an additive risk factor for hormonal contraception related thrombosis
|
Habiger, Clayton
|
|
|
|
S1 |
p.
|
artikel
|
| 20 |
HTRS2023.O6B.2 Allosteric regulation of coagulation factor IXa
|
Kolyadko, Vladimir N.
|
|
|
|
S1 |
p.
|
artikel
|
| 21 |
HTRS2023.O8B.3 Elucidating the molecular mechanism of excessive phosphatidylserine exposure in sickle red cells
|
Liang, Pengfei
|
|
|
|
S1 |
p.
|
artikel
|
| 22 |
HTRS2023.O8B.4 Fatty acid oxidation fuels agonist-induced platelet activation and thrombus formation: targeting beta-oxidation of fatty acids as an effective anti-platelet strategy
|
Kulkarni, Paresh P.
|
|
|
|
S1 |
p.
|
artikel
|
| 23 |
HTRS2023.O6B.3 FVIII deficiency leads to lower atherogenic ApoB-lipoprotein and higher fibrinolysis
|
Zhang, Ziyu
|
|
|
|
S1 |
p.
|
artikel
|
| 24 |
HTRS2023.O6B.4 FXIII-mediated cross-linking of hepatic fibrin is a critical driver of platelet accumulation and liver regeneration after partial hepatectomy
|
Luyendyk, James
|
|
|
|
S1 |
p.
|
artikel
|
| 25 |
HTRS2023.O8B.1 HIF-1 inhibition attenuates venous thrombosis in JAK2V617F transgenic mice
|
Reeves, Brandi
|
|
|
|
S1 |
p.
|
artikel
|
| 26 |
HTRS2023.O6B.1 Interaction of antithrombin with vascular GAGs is required for its anti-inflammatory signaling but not anticoagulant protease-inhibitory function
|
Biswas, Indranil
|
|
|
|
S1 |
p.
|
artikel
|
| 27 |
HTRS2023.O8B.2 Proteome and phosphoproteome analyses of SARS-CoV-2 infected humanized ACE2 mice platelets reveal early hyperactive and late antiviral phenotypes
|
Subramaniam, Saravanan
|
|
|
|
S1 |
p.
|
artikel
|
| 28 |
HTRS2023.O8C.2 Eptacog beta efficacy and safety in underweight, normal weight, and overweight/obese persons with hemophilia A or B and inhibitors
|
Rafique, Amina
|
|
|
|
S1 |
p.
|
artikel
|
| 29 |
HTRS2023.O8C.1 Subcutaneous concizumab prophylaxis in patients with hemophilia A or B with inhibitors: efficacy, safety, and physical activity score, primary analysis from the phase 3 explorer7 trial
|
Wheeler, Allison P.
|
|
|
|
S1 |
p.
|
artikel
|
| 30 |
HTRS2023.O8C.4 Subject with infertility due to congenital plasminogen deficiency type 1: results of plasminogen replacement therapy and impact of varying dosage regimen during treatment and maintenance phases
|
Thibaudeau, Karen
|
|
|
|
S1 |
p.
|
artikel
|
| 31 |
HTRS2023.P2.14 A case of thrombosis in acquired hemophilia A
|
Vijayvargiya, Pooja
|
|
|
|
S1 |
p.
|
artikel
|
| 32 |
HTRS2023.P4.13 Antibody mediated pathophysiology of immune thrombotic thrombocytopenic purpura
|
Halkidis, Konstantine
|
|
|
|
S1 |
p.
|
artikel
|
| 33 |
HTRS2023.P2.7 Burden of disease and impact on quality of life in hereditary factor X deficiency patients receiving prophylaxis: findings from the Hereditary Factor X Deficiency in America survey
|
Garner, Denise A.
|
|
|
|
S1 |
p.
|
artikel
|
| 34 |
HTRS2023.P2.6 Burden of disease and impact on quality of life in hereditary factor X deficiency patients who have experienced menorrhagia: findings from the Hereditary Factor X Deficiency in America survey
|
Stanford, Richard H.
|
|
|
|
S1 |
p.
|
artikel
|
| 35 |
HTRS2023.P1.6 Characterization and expression of atypical type 2B variants in the Zimmerman Program
|
Christopherson, Pamela A.
|
|
|
|
S1 |
p.
|
artikel
|
| 36 |
HTRS2023.P1.4 Characterization of the binding interaction between factor XII and integrin αIIbβ3
|
Bertovich, Dylan T.
|
|
|
|
S1 |
p.
|
artikel
|
| 37 |
HTRS2023.P3.2 Clinical outcomes in patients with acute hepatic porphyria treated with givosiran who stopped hemin prophylaxis at study entry: post hoc analyses from the phase 3 ENVISION study through month 36
|
Deering, Robert W.
|
|
|
|
S1 |
p.
|
artikel
|
| 38 |
HTRS2023.P2.20 Common documentation errors in the electronic health records of persons with hemophilia B
|
Cibelli, Emily
|
|
|
|
S1 |
p.
|
artikel
|
| 39 |
HTRS2023.P1.1 Comparison of light transmission and whole blood lumiaggregometry in evaluation of pediatric patients for platelet function disorders
|
Thompson, Eric N.
|
|
|
|
S1 |
p.
|
artikel
|
| 40 |
HTRS2023.P3.6 Correlation of non-invasive hemoglobin measurement with bleeding during cesarean delivery: the PPHgb study
|
Ebner, Megan
|
|
|
|
S1 |
p.
|
artikel
|
| 41 |
HTRS2023.P3.7 Descriptive analysis of a pediatric anticoagulation stewardship initiative to improve anticoagulation safety: a quality improvement project
|
Salas, Niavana M.
|
|
|
|
S1 |
p.
|
artikel
|
| 42 |
HTRS2023.P4.4 DOAC compared with warfarin for VTE in underweight patients: a retrospective cohort study conducted through the VENUS Network
|
Martin, Karlyn A.
|
|
|
|
S1 |
p.
|
artikel
|
| 43 |
HTRS2023.P3.4 EAGeR (Empower Adolescent Girls): a multidisciplinary approach to iron deficiency anemia related to heavy menstrual bleeding
|
Bhatt, Nidhi
|
|
|
|
S1 |
p.
|
artikel
|
| 44 |
HTRS2023.P4.1 Effect of heparin induced thrombocytopenia on outcomes of pulmonary embolism: a nationwide inpatient sample study
|
Obeidat, Khaldun
|
|
|
|
S1 |
p.
|
artikel
|
| 45 |
HTRS2023.P4.10 Endothelial ERp46 supports tissue factor activity
|
Guo, Shihui
|
|
|
|
S1 |
p.
|
artikel
|
| 46 |
HTRS2023.P2.22 Evaluating the effectiveness and safety of damoctocog alfa pegol prophylaxis in hemophilia A patients with a history of factor VIII inhibitors from the real-world HEM-POWR study
|
Reding, Mark T.
|
|
|
|
S1 |
p.
|
artikel
|
| 47 |
HTRS2023.P2.9 Fitusiran prophylaxis demonstrates sustained bleed protection in people with hemophilia A or B: an exploratory analysis of antithrombin levels and peak thrombin generation from three phase 3 trials
|
Pipe, Steven W.
|
|
|
|
S1 |
p.
|
artikel
|
| 48 |
HTRS2023.P2.3 F8 variants in women and girls evaluated for hemophilia A
|
Sandoval, Claudio
|
|
|
|
S1 |
p.
|
artikel
|
| 49 |
HTRS2023.P1.3 HMGB1 contributes to platelet activation in sickle cell disease through enhancement of purinergic signaling
|
Nolfi-Donegan, Deirdre
|
|
|
|
S1 |
p.
|
artikel
|
| 50 |
HTRS2023.P4.3 Identifying barriers and facilitators to inform implementation strategies for venous thromboembolism prevention in oncology practice using the Implementation Research Logic Model
|
Martin, Karlyn A.
|
|
|
|
S1 |
p.
|
artikel
|
| 51 |
HTRS2023.P4.18 Improving anticoagulation care for pediatric oncology patients
|
Rodriguez, Vilmarie
|
|
|
|
S1 |
p.
|
artikel
|
| 52 |
HTRS2023.P4.2 Improving judicious use of heparin induced thrombocytopenia laboratory testing using a clinician decision support tool
|
Machhi, Rushad
|
|
|
|
S1 |
p.
|
artikel
|
| 53 |
HTRS2023.P4.9 Inflammation leads to short-term GAS6 elevation followed by longer-term MERTK increase, but does not influence protein S Levels, in murine plasma
|
Judd, Samantha
|
|
|
|
S1 |
p.
|
artikel
|
| 54 |
HTRS2023.P3.1 Iron deficiency in a large pediatric comprehensive bleeding disorders clinic: current screening practice and iron deficiency prevalence
|
Stone, Elizabeth A.
|
|
|
|
S1 |
p.
|
artikel
|
| 55 |
HTRS2023.P2.5 Joint surveillance with ultrasound in pediatric hemophilia A patients on emicizumab: a single institution retrospective review
|
Picca, Andrew
|
|
|
|
S1 |
p.
|
artikel
|
| 56 |
HTRS2023.P1.5 Macrothrombocytopenia, significantly elevated IPF, and severe epistaxis mistaken for ITP: a case report of GNE-related thrombocytopenia
|
Nguyen, Gabriella
|
|
|
|
S1 |
p.
|
artikel
|
| 57 |
HTRS2023.P2.2 Mim8 clinical development program: an overview of FRONTIER studies with results from a multiple ascending dose study of Mim8 in patients with severe hemophilia A with or without factor VIII inhibitors
|
Lentz, Steven
|
|
|
|
S1 |
p.
|
artikel
|
| 58 |
HTRS2023.P4.21 Multi-ancestry GWAS for venous thromboembolism identifies novel loci after validation in zebrafish
|
Zhao, Yakun
|
|
|
|
S1 |
p.
|
artikel
|
| 59 |
HTRS2023.P2.13 Off-target toxicity of CART cell therapy in murine hemophilia A with inhibitors
|
Hresko, Morgan
|
|
|
|
S1 |
p.
|
artikel
|
| 60 |
HTRS2023.P4.7 Outcomes of pulmonary embolism in patients with autoimmune hemolytic anemia: a National Inpatient Sample (NIS) study
|
Deenadayalan, Vaishali
|
|
|
|
S1 |
p.
|
artikel
|
| 61 |
HTRS2023.P4.8 Pediatric patients diagnosed with a pulmonary embolism are more likely to be diagnosed with dyspnea three or more months after diagnosis: a population-based analysis
|
Robson, Lydia S.
|
|
|
|
S1 |
p.
|
artikel
|
| 62 |
HTRS2023.P2.18 Pediatric persons with hemophilia A on EHL-FVIII or emicizumab prophylaxis require iron therapy despite low annualized bleeding rate
|
Garcia, Jessica
|
|
|
|
S1 |
p.
|
artikel
|
| 63 |
HTRS2023.P4.12 Perceptions on the potential for artificial intelligence to improve venous thromboembolism prevention
|
Lam, Barbara D.
|
|
|
|
S1 |
p.
|
artikel
|
| 64 |
HTRS2023.P2.11 Personalized prophylaxis with simoctocog alfa in adult Japanese previously treated patients with severe hemophilia A
|
Nishida, Yasuharu
|
|
|
|
S1 |
p.
|
artikel
|
| 65 |
HTRS2023.P4.11 Platelet-associated beta-2 glycoprotein 1 inhibits agonist-induced platelet activation which is relieved by proteolytic cleavage
|
Hubben, Anne K.
|
|
|
|
S1 |
p.
|
artikel
|
| 66 |
HTRS2023.P2.16 Prevalence of iron deficiency in patients with inherited bleeding disorders
|
Cochran, Thomas R.
|
|
|
|
S1 |
p.
|
artikel
|
| 67 |
HTRS2023.P2.12 Reactivation of factor 8 inhibitor on emicizumab prophylaxis in a previously tolerized patient
|
Jain, Akshat
|
|
|
|
S1 |
p.
|
artikel
|
| 68 |
HTRS2023.P3.5 Screening for abnormal uterine bleeding in adolescents presenting to primary care clinics
|
Mitchell, Sarah
|
|
|
|
S1 |
p.
|
artikel
|
| 69 |
HTRS2023.P2.10 Structured assessments and clinical phenotypes in bleeding of unknown cause
|
Berkowitz, Callie
|
|
|
|
S1 |
p.
|
artikel
|
| 70 |
HTRS2023.P4.20 Systematic review of global hemostasis assays in myeloproliferative neoplasms: promising tools for biomarkers for hypercoagulability
|
Tiu, Andrew C.
|
|
|
|
S1 |
p.
|
artikel
|
| 71 |
HTRS2023.P2.19 Treatment burden and unmet needs in hemophilia patients with inhibitors: results from a real-world observational study in the United States
|
Shah, Sanket
|
|
|
|
S1 |
p.
|
artikel
|
| 72 |
HTRS2023.P2.15 Treatment burden, patient preference, and health-related quality of life in patients with hemophilia A or B with inhibitors on concizumab prophylaxis: results from the phase 3 explorer7 study
|
Wheeler, Allison P.
|
|
|
|
S1 |
p.
|
artikel
|
| 73 |
HTRS2023.P3.3 Using anti-Xa monitoring to manage anticoagulation for mechanical heart valves during pregnancy
|
Frank, Annabel K.
|
|
|
|
S1 |
p.
|
artikel
|
| 74 |
HTRS2023.P4.14 Using heparin-calibrated assays to estimate anti-factor Xa activity of factor Xa inhibitors: correlation analysis of published data
|
Sarode, Ravi
|
|
|
|
S1 |
p.
|
artikel
|
| 75 |
HTRS2023.P2.1 Will my patient bleed? Management and outcomes for patients with severe FXI deficiency
|
Wu, Shin-Rong J.
|
|
|
|
S1 |
p.
|
artikel
|
| 76 |
ISTH Abstract
|
|
|
|
|
S1 |
p.
|
artikel
|
| 77 |
Nurses and Orals Abstracts
|
|
|
|
|
S1 |
p. 1-228
|
artikel
|
| 78 |
Oral Communication abstracts
|
|
|
|
|
S1 |
p.
|
artikel
|
| 79 |
Oral Communication Abstracts
|
|
|
|
|
S1 |
p. 1-44
|
artikel
|
| 80 |
Posters Abstracts
|
|
|
|
|
S1 |
p. 1-1311
|
artikel
|
| 81 |
Posters Abstracts
|
|
|
|
|
S1 |
p. 1-891
|
artikel
|
| 82 |
Title page
|
|
|
|
|
S1 |
p.
|
artikel
|
Tijdschrift beschrijving